MA28561B1 - Utilisation d'agonistes du recepteur delta active par les proliferateurs de peroxysomes pour le traitement de la sep et d'autres maladies demyelinisantes - Google Patents
Utilisation d'agonistes du recepteur delta active par les proliferateurs de peroxysomes pour le traitement de la sep et d'autres maladies demyelinisantesInfo
- Publication number
- MA28561B1 MA28561B1 MA29427A MA29427A MA28561B1 MA 28561 B1 MA28561 B1 MA 28561B1 MA 29427 A MA29427 A MA 29427A MA 29427 A MA29427 A MA 29427A MA 28561 B1 MA28561 B1 MA 28561B1
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- receptor agonists
- delta receptor
- peroxisome proliferative
- active delta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55853304P | 2004-04-01 | 2004-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28561B1 true MA28561B1 (fr) | 2007-04-03 |
Family
ID=34977094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29427A MA28561B1 (fr) | 2004-04-01 | 2006-10-31 | Utilisation d'agonistes du recepteur delta active par les proliferateurs de peroxysomes pour le traitement de la sep et d'autres maladies demyelinisantes |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070149580A1 (fr) |
EP (1) | EP1737440A2 (fr) |
JP (1) | JP2007530703A (fr) |
KR (1) | KR20060134191A (fr) |
CN (1) | CN1950077A (fr) |
AU (1) | AU2005231358A1 (fr) |
BR (1) | BRPI0509540A (fr) |
CA (1) | CA2561159A1 (fr) |
IL (1) | IL178165A0 (fr) |
MA (1) | MA28561B1 (fr) |
MX (1) | MXPA06011218A (fr) |
NO (1) | NO20064985L (fr) |
RU (1) | RU2006138495A (fr) |
SG (1) | SG138623A1 (fr) |
WO (1) | WO2005097098A2 (fr) |
ZA (1) | ZA200607850B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1745014B1 (fr) | 2004-05-05 | 2011-07-06 | High Point Pharmaceuticals, LLC | Nouveaux composes, leur preparation et leur utilisation |
JP2007536343A (ja) | 2004-05-05 | 2007-12-13 | ノボ ノルディスク アクティーゼルスカブ | Pparアゴニストとしてのフェノキシ酢酸誘導体 |
ATE529404T1 (de) | 2005-06-30 | 2011-11-15 | High Point Pharmaceuticals Llc | Phenoxyessigsäuren als ppar-delta-aktivatoren |
KR101409705B1 (ko) * | 2005-11-28 | 2014-07-14 | 센주 세이야꾸 가부시키가이샤 | Ppar 아고니스트 함유 의약 |
EA015717B1 (ru) | 2005-12-22 | 2011-10-31 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Феноксиуксусные кислоты в качестве активаторов ppar дельта |
EP1999098A2 (fr) | 2006-03-09 | 2008-12-10 | High Point Pharmaceuticals, LLC | Nouveaux composés, leur préparation et utilisation |
AU2009256982A1 (en) | 2008-06-09 | 2009-12-17 | Sanofi-Aventis | Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
EP2288607B1 (fr) | 2008-06-09 | 2014-09-24 | Sanofi | Sulfonamides comprenant un hétérocycle et un groupe de tête oxadiazolone, procédés pour les préparer et leur utilisation comme produits pharmaceutiques |
CA2774999A1 (fr) | 2009-09-30 | 2011-04-07 | President And Fellows Of Harvard College | Procedes de modulation de l'autophagie par la modulation de produits geniques renforcant l'autophagie |
AU2010340238B2 (en) | 2009-12-17 | 2016-07-21 | Sanofi | Animal model expressing luciferase under control of the myelin basic protein promoter (MBP-luci) and use of the model for bioluminescence in vivo imaging |
EP2675893B1 (fr) * | 2011-02-18 | 2019-01-09 | The Scripps Research Institute | Différenciation dirigée de cellules précurseurs d'oligodendrocytes vers un destin cellulaire myélinisant |
US9487493B2 (en) | 2013-09-09 | 2016-11-08 | Vtv Therapeutics Llc | Use of a PPAR-delta agonist for treating muscle atrophy |
WO2023147309A1 (fr) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Utilisation d'agonistes ppar-delta dans le traitement d'une maladie |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1856997A (en) * | 1996-02-02 | 1997-08-22 | Merck & Co., Inc. | Method for raising hdl cholesterol levels |
GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
WO2002013812A1 (fr) * | 2000-08-17 | 2002-02-21 | Pershadsingh Harrihar A | Traitements de maladies inflammatoires |
GB0024362D0 (en) * | 2000-10-05 | 2000-11-22 | Glaxo Group Ltd | Medicaments |
GB0024361D0 (en) * | 2000-10-05 | 2000-11-22 | Glaxo Group Ltd | Medicaments |
US20050020654A1 (en) * | 2003-03-15 | 2005-01-27 | Pershadsingh Harrihar A. | Novel PPAR agonists, pharmaceutical compositions and uses thereof |
EP1637161A4 (fr) * | 2003-04-22 | 2007-06-27 | Astellas Pharma Inc | REMEDE CONTRE DES MALADIES CEREBRALES NEURODEGENERATIVES UTILISANT UN AGONISTE DES PPAR [delta] |
-
2005
- 2005-03-29 EP EP05729215A patent/EP1737440A2/fr not_active Withdrawn
- 2005-03-29 MX MXPA06011218A patent/MXPA06011218A/es not_active Application Discontinuation
- 2005-03-29 JP JP2007506442A patent/JP2007530703A/ja not_active Abandoned
- 2005-03-29 RU RU2006138495/14A patent/RU2006138495A/ru not_active Application Discontinuation
- 2005-03-29 AU AU2005231358A patent/AU2005231358A1/en not_active Abandoned
- 2005-03-29 WO PCT/US2005/010371 patent/WO2005097098A2/fr active Application Filing
- 2005-03-29 BR BRPI0509540-9A patent/BRPI0509540A/pt not_active IP Right Cessation
- 2005-03-29 SG SG200800123-2A patent/SG138623A1/en unknown
- 2005-03-29 CA CA002561159A patent/CA2561159A1/fr not_active Abandoned
- 2005-03-29 KR KR1020067022955A patent/KR20060134191A/ko not_active Application Discontinuation
- 2005-03-29 CN CNA2005800148506A patent/CN1950077A/zh active Pending
-
2006
- 2006-09-18 IL IL178165A patent/IL178165A0/en unknown
- 2006-09-19 ZA ZA200607850A patent/ZA200607850B/xx unknown
- 2006-09-26 US US11/535,240 patent/US20070149580A1/en not_active Abandoned
- 2006-10-31 NO NO20064985A patent/NO20064985L/no not_active Application Discontinuation
- 2006-10-31 MA MA29427A patent/MA28561B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20070149580A1 (en) | 2007-06-28 |
AU2005231358A1 (en) | 2005-10-20 |
CA2561159A1 (fr) | 2005-10-20 |
BRPI0509540A (pt) | 2007-09-18 |
CN1950077A (zh) | 2007-04-18 |
ZA200607850B (en) | 2008-10-29 |
RU2006138495A (ru) | 2008-05-10 |
JP2007530703A (ja) | 2007-11-01 |
EP1737440A2 (fr) | 2007-01-03 |
KR20060134191A (ko) | 2006-12-27 |
SG138623A1 (en) | 2008-01-28 |
MXPA06011218A (es) | 2007-01-16 |
NO20064985L (no) | 2006-10-31 |
IL178165A0 (en) | 2008-03-20 |
WO2005097098A3 (fr) | 2005-12-22 |
WO2005097098A2 (fr) | 2005-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28561B1 (fr) | Utilisation d'agonistes du recepteur delta active par les proliferateurs de peroxysomes pour le traitement de la sep et d'autres maladies demyelinisantes | |
FR13C0060I2 (fr) | Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques | |
FR2867778B1 (fr) | Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme | |
FR16C1012I2 (fr) | Utilisation therapeutique d'anticorps anti-cs1 | |
MA26852A1 (fr) | Agonistes selectifs du recepteur ep4 pour le traitement de l'osteoporose | |
FR2854074B1 (fr) | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques | |
MA28689B1 (fr) | Derives de pyrrozolotriazine utiles pour le traitement des troubles et maladies hyperproliferatifs associes a l'angiogenese | |
DE60233040D1 (de) | Guanylat-cyclase-rezeptor-agonisten zur behandlung von gewebeentzündung und karzinogenese | |
BRPI0418245A (pt) | nitróxi-derivados de prostaglandina | |
DE60238149D1 (de) | Arylsulfonamid-Derivate zur Verwendung als CCR3-Antagonisten bei der Behandlung von inflammatorischen und immunologischen Erkrankungen | |
MA27028A1 (fr) | Agoniste de recepteur d'adenosine a2a et agent anticholinergique en association pour le traitement de maladies obstructives des voies aeriennes | |
FR2887450B1 (fr) | Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques | |
MA33381B1 (fr) | Proteine de liaison a il-13 | |
MA26230A1 (fr) | Agents antidysrythmiques administres par voie vaginale utilises pour traiter les douleurs pelviennes et la sterilite | |
MA29085B1 (fr) | Agent prophylactique ou thérapeutique pour le traitement des troubles du sommeil | |
DK1458399T3 (da) | Pregnansteroider til brug i behandlingen af CNS-sygdomme | |
ITMI20040876A1 (it) | Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari | |
FR2857597B1 (fr) | Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie. | |
FR2889068B1 (fr) | Nouvelles fractions proteiques laitieres et leur utilisation pour la prevention ou le traitement des maladies inflammatoires chroniques | |
FR2908658B1 (fr) | Composition pour la prevention et/ou le traitement des maladies associees a la surexpression du tnf et/ou de l'il-12 | |
EE200400074A (et) | Koostised ning nende kasutamine proliferatiivsetehaiguste raviks | |
FR2865736B1 (fr) | Inhibiteurs de l'angiogenese, compositions les contenant et leur utilisation pour le traitement des maladies liees a une deregulation de l'angiogenese | |
DZ3320A1 (fr) | Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine | |
FR2912055B1 (fr) | Composition cosmetique comprenant des actifs anti-inflammatoires, reparateurs, apaisants et hydratants pour calmer l'irritation de la peau | |
FR2883477B1 (fr) | Nouvelle utilisation de la tritoqualine pour le traitement des maladies inflamatoires digestives et plus particulierement gastriques et oesophagiennes |